SLC5A2 and hydrops fetalis: Furthermore, in accordance with the conventional treatment approach for T2D, many patients with T2D at risk of developing HF, or even those with existing HF, had been taking metformin and/or combination therapy of glucose-lowering agents prior to the initiation of SGLT2 inhibitors.